These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 16110881)

  • 21. Current status of regulating biotechnology-derived animals in Canada: animal health and food safety considerations.
    Kochhar HP; Evans BR
    Theriogenology; 2007 Jan; 67(1):188-97. PubMed ID: 17097725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Public perceptions of transgenic animals.
    Einsiedel EF
    Rev Sci Tech; 2005 Apr; 24(1):149-57. PubMed ID: 16110885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xenotransplantation: an ethical dilemma.
    George JF
    Curr Opin Cardiol; 2006 Mar; 21(2):138-41. PubMed ID: 16470151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biodiversity and emerging diseases.
    Maillard JC; Gonzalez JP
    Ann N Y Acad Sci; 2006 Oct; 1081():1-16. PubMed ID: 17135490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Important points in virus research using recombinant DNA technology].
    Nikaido T; Takeuchi K
    Uirusu; 2007 Jun; 57(1):91-100. PubMed ID: 18040159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Establishment of the bill on living modified organisms (LMOs) and its background].
    Yoda J
    Tanpakushitsu Kakusan Koso; 2004 Mar; 49(4):559-66. PubMed ID: 15024846
    [No Abstract]   [Full Text] [Related]  

  • 27. Environmental protection: applying the precautionary principle and proactive regulation to biotechnology.
    Richmond RH
    Trends Biotechnol; 2008 Aug; 26(8):460-7. PubMed ID: 18584904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of transgenic animals in biotechnology.
    Ebert KM
    Int J Dev Biol; 1998; 42(7):1003-8. PubMed ID: 9853831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory considerations for biotechnology-derived animals in Canada.
    Kochhar HP; Adlakha-Hutcheon G; Evans BR
    Rev Sci Tech; 2005 Apr; 24(1):117-25. PubMed ID: 16110882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulatory framework for genetically modified organisms in the Kingdom of Eswatini.
    Nkhabindze BZ; Magagula CN; Earnshaw D; Mhlanga CF; Matsebula SN; Dladla IG
    GM Crops Food; 2024 Dec; 15(1):212-221. PubMed ID: 38963885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Human ecology and interdisciplinary cooperation for primary prevention of environmental risk factors for public health].
    Dobrowolski JW
    Przegl Lek; 2007; 64 Suppl 4():35-41. PubMed ID: 18540323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of animal biotechnology: research needs.
    Rexroad CE; Green RD; Wall RJ
    Theriogenology; 2007 Sep; 68 Suppl 1():S3-8. PubMed ID: 17574657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Cartagena Protocol on Biosafety: interaction between the Convention on Biological Diversity and the World Organisation for Animal Health.
    Sendashonga C; Hill R; Petrini A
    Rev Sci Tech; 2005 Apr; 24(1):19-30. PubMed ID: 16110874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetically modified animals for use in research and biotechnology.
    Chaible LM; Corat MA; Abdelhay E; Dagli ML
    Genet Mol Res; 2010 Jul; 9(3):1469-82. PubMed ID: 20677136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulations governing veterinary medicinal products containing genetically modified organisms in the European community.
    Moulin G
    Rev Sci Tech; 2005 Apr; 24(1):101-7. PubMed ID: 16110880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Science of evaluating the characteristics, quality and safety of biotechnological products: RDNA-derived products, cell culture technology-derived products, gene therapy products, cellular therapy products, and transgenic animal-derived protein products and cellular products].
    Hayakawa T
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1999; (117):1-38. PubMed ID: 10859934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interface of biotechnology and ecology for environmental risk assessments of transgenic fish.
    Devlin RH; Sundström LF; Muir WM
    Trends Biotechnol; 2006 Feb; 24(2):89-97. PubMed ID: 16380181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. US regulatory system for genetically modified [genetically modified organism (GMO), rDNA or transgenic] crop cultivars.
    McHughen A; Smyth S
    Plant Biotechnol J; 2008 Jan; 6(1):2-12. PubMed ID: 17956539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New vaccines and new veterinary therapies derived from biotechnologies: examples of applications].
    Vannier P; Martignat L
    Rev Sci Tech; 2005 Apr; 24(1):215-29. PubMed ID: 16110890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Genetically Modified Organism Medicinal Framework in Europe, United States, and Japan: Underlying Scientific Principles and Considerations Toward the Development of Gene Therapy and Genetically Modified Cell-Based Products.
    Bachtarzi H; Farries T
    Hum Gene Ther Clin Dev; 2019 Sep; 30(3):114-128. PubMed ID: 31111736
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.